Surgeons test precise lymph node removal for stomach cancer

NCT ID NCT07183150

Recruiting now Knowledge-focused Sponsor: Tianjin Medical University Cancer Institute and Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study aims to find the best range for removing No.4sb lymph nodes during surgery for advanced stomach cancer. Researchers will track 400 patients to see how often cancer spreads to different parts of these lymph nodes. The goal is to help surgeons remove only the necessary nodes, improving recovery and reducing complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help surgeons know exactly which lymph nodes to remove during gastric cancer surgery, potentially reducing recurrence and side effects.
What could go wrong: This is an early-stage observational study, not a treatment trial. Results may not apply to all patients, and the findings are about surgical technique, not a new drug or cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CANCER (GC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric cancer gastric neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTRIC CANCER (GC) NO.4SB

Contacts and locations

Locations

Tianjin Medical University Cancer Hospital
RECRUITING

Tianjin, Tianjin Municipality, 300060, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.